RESUMO
PURPOSE: To evaluate the effect of being under time pressure on procedural performance using hand motion analysis. MATERIALS AND METHODS: Eight radiology trainees performed central venous access on a phantom while recording video and hand motion data using an electromagnetic motion tracker. Each trainee performed the procedure six times: the first three trials without any prompts (control), while for the next three, they were asked to perform the task as fast as possible (time pressure). Validated hand motion metrics were analyzed, and two blinded and independent evaluators rated procedural performance using a previously validated task-specific global rating scale (GRS). Motion/time ratios and linear mixed-effect methods were used to control for time, and constants for both strategies were compared. RESULTS: Hand motion analysis showed that trainees completed the simulated procedure faster under time pressure (46 ± 18 s vs. 56 ± 27 s, p = 0.008) than during the control strategy. However, when controlling for time, trainees moved their hands 79 more centimeters (p = 0.04), made 15 more translational movements (p = 0.003) and 18 more rotational movements (p = 0.01) when under time pressure compared to at their own pace. CONCLUSION: Although trainees could perform the procedure faster under time pressure, there was a deterioration in hand motion economy and smoothness. This suggests that hand motion metrics offer a more comprehensive assessment of technical performance than time alone.
RESUMO
PURPOSE: To test the hypothesis that hand motion analysis can measure the progression of needle and ultrasound probe manipulation skills of interventional radiology trainees in central venous line placement. MATERIALS AND METHODS: An expert cohort of 6 interventional radiologists and 4 anesthesiologists and a trainee cohort of 6 novice trainees (<50 central lines) and 5 experienced trainees (>50 central lines) performed simulated central venous access. Four novices and 1 experienced trainee repeated the task 1 year later. An electromagnetic motion tracking system tracked the needle hand and ultrasound probe. Path length, translational, and rotational movements were calculated separately for the needle hand and probe sensor. These metrics were used to calculate motion metrics based scores on a scale of 0 to 3 for each sensor. Nonparametric statistics were used, and the data are reported as median ± interquartile range. RESULTS: Comparing novice and experienced trainees, there was a significant difference in probe scores (experienced vs. novice: 1 ± 2 vs. 0 ± 0, P = 0.04) but not in needle-hand scores (1 ± 1.5 vs. 0 ± 1, P = 0.26). Trainees showed a significant increase in probe scores at the 1-year follow-up (baseline vs. follow-up: 0 ± 1 vs. 2.5 ± 1.8, P = 0.003), but no significant difference was observed in the needle manipulation metrics. Experts differed significantly from experienced trainees for all metrics for both sensors (P < 0.05), with the exception of the path length of the probe. CONCLUSIONS: Acquisition of improved dexterity of the probe may occur before improvement in the dexterity with the needle hand for interventional radiology trainees.
RESUMO
Background: The Japanese 2020 cervical screening guidelines recommend conventional cervical cytology screening every 2-years for women aged 20-69 years. The nonavalent human papillomavirus (HPV) vaccine has also recently been approved in Japan. We therefore evaluated the cost-effectiveness of cervical cancer screening strategies alongside universal nonavalent HPV vaccination of girls (12-16 years). Methods: A cost-effectiveness analysis was performed using an age-specific Markov microsimulation model for Japan to evaluate total costs, quality adjusted life-years (QALYs) gained, incremental cost-effectiveness ratios (ICER), colposcopies, biopsies, precancer and cervical cancer treatments for 29 combined vaccination and screening strategies (conventional cytology, liquid-based cytology (LBC), HPV testing, and HPV self-collection). A cohort of 100,000 girls (12-16 years old) over a lifetime offered the nonavalent HPV vaccine was used (current vaccination coverage = 0.08%, current screening coverage = 43.7%). A discount rate of 3% was applied to costs and QALYs. Univariate and probabilistic sensitivity analysis was performed to assess robustness of the findings. Costs were reported in US dollars (2023). Findings: Compared with conventional cytology, evaluated strategies would incur an additional cost of US$839,280-738,182,669 and gain 62,755-247,347 quality-adjusted-life-years. HPV testing distinguishing HPV16/18 with reflex LBC (3-yearly) would be most cost-effective (ICER = US$7511 per QALY gained). At a willingness-to-pay (WTP) of 1-times gross domestic product (GDP) per capita, the probability of it being cost-effective was 70%. At historically high vaccination coverage (70%) ICERs decreased overall but did not affect the ranking of the most cost-effective strategy. While a 5-yearly interval became more cost-effective than a 3-yearly interval. Including HPV self-collection for under-screened women made all strategies more cost-effective. Interpretation: At current cervical screening participation (43.7%) and low vaccination coverage (<1.0%), HPV testing distinguishing HPV16/18 with reflex LBC (3-yearly) would be the most cost-effective screening strategy compared to conventional cytology (2-yearly). Funding: Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (17H03589) and Grants of the National Cancer Center Japan (Gan Kenkyu Kaihatsuhi 31-A-20 and 2023-A-23).
RESUMO
PURPOSE: To evaluate the ability of hand motion analysis using conventional and new motion metrics to differentiate between operators of varying levels of experience for central venous access (CVA) and liver biopsy (LB). MATERIALS AND METHODS: In the CVA task, 7 interventional radiologists (experts), 10 senior trainees, and 5 junior trainees performed ultrasound-guided CVA on a standardized manikin; 5 trainees were retested after 1 year. In the LB task, 4 radiologists (experts) and 7 trainees biopsied a lesion on a manikin. Conventional motion metrics (path length and task time), a refined metric (translational movements), and new metrics (rotational sum and rotational movements) were calculated. RESULTS: In the CVA task, experts outperformed trainees on all metrics (P < .02). Senior trainees required fewer rotational movements (P = .02), translational movements (P = .045), and time (P = .001) than junior trainees. Similarly, on 1-year follow-up, trainees had fewer translational (P = .02) and rotational (P = .003) movements with less task time (P = .003). The path length and rotational sum were not different between junior and senior trainees or for trainees on follow-up. Rotational and translational movements had greater area under the curve values (0.91 and 0.86, respectively) than the rotational sum (0.73) and path length (0.61). In the LB task, experts performed the task with a shorter path length (P = .04), fewer translational (P = .04) and rotational (P = .02) movements, and less time (P < .001) relative to the trainees. CONCLUSIONS: Hand motion analysis using translational and rotational movements was better at differentiating levels of experience and improvement with training than the conventional metric of path length.
Assuntos
Benchmarking , Internato e Residência , Humanos , Mãos , Ultrassonografia , Competência Clínica , Ultrassonografia de IntervençãoRESUMO
PURPOSE: To develop a scheme to quantitatively assess localization accuracy of tomosynthesis-guided vacuum-assisted breast biopsy apparatus. METHODS: A phantom containing a metallic pellet on a flexible plastic shaft was constructed and was tested in cranio-caudal (CC) and lateral (LAT) arm biopsy geometries following the standard clinical breast biopsy workflow. Three points were manually digitized on tomosynthesis images including: the center of the target, and the tip of the needle in pre- and postfire positions. The needle trajectory was determined and four error metrics were defined: (1) stroke length error (difference between the nominal and measured stroke lengths); (2) Euclidian distance between the target and center of trough (i.e., aperture); (3) longitudinal distance between target and center of trough; and (4) lateral distance between target and needle. The proposed methodology was also evaluated on a breast gel phantom and the complete biopsy procedure, including vacuum-assisted biopsy was performed. RESULTS: Three biopsy geometries were investigated: (i) LAT arm on a prone table unit (Hologic, Affirm Prone), (ii) CC- and (iii) LAT arm in an upright unit (Hologic Affirm Upright). Both biopsy units passed the vendor-provided daily localization accuracy test, with <1 mm nominal error in each dimension. The aforementioned error metrics (1) to (4) were (0.6, 1.8, 0.4, 1.7) mm, (0.4, 4.2, 4.1, 1.1) mm, and (0.3, 2.4, 0.7, 2.3) mm, respectively, for geometry-I, -II, and -III. The gel phantom was tested on the upright unit with lateral arm and the error metrics (1) to (4) were 0.4, 2.5, 0.8, and 2.4 mm respectively. CONCLUSIONS: A framework was developed to evaluate the tomosynthesis-guided breast biopsy localization error, allowing quantitative comparisons between different systems and biopsy configurations. The proposed framework can also be extended to the stereotactic breast biopsy units. We suggest that a quantitative tolerance level for localization accuracy of breast biopsy units be established.
Assuntos
Neoplasias da Mama , Mama , Biópsia por Agulha , Mama/diagnóstico por imagem , Neoplasias da Mama/diagnóstico por imagem , Humanos , Biópsia Guiada por Imagem , Imageamento Tridimensional , Imagens de FantasmasRESUMO
PURPOSE: To prospectively validate electromagnetic hand motion tracking in interventional radiology to detect differences in operator experience using simulation. METHODS: Sheath task: Six attending interventional radiologists (experts) and 6 radiology trainees (trainees) placed a wire through a sheath and performed a "pin-pull" maneuver, while an electromagnetic motion detection system recorded the hand motion. Radial task: Eight experts and 12 trainees performed palpatory radial artery access task on a radial access simulator. The trainees repeated the task with the nondominant hand. The experts were classified by their most frequent radial artery access technique as having either palpatory, ultrasound, or overall limited experience. The time, path length, and number of movements were calculated. Mann-Whitney U tests were used to compare the groups, and P < .05 was considered significant. RESULTS: Sheath task: The experts took less time, had shorter path lengths, and used fewer movements than the trainees (11.7 seconds ± 3.3 vs 19.7 seconds ± 6.5, P < .01; 1.1 m ± 0.3 vs 1.4 m ± 0.4, P < .01; and 19.5 movements ± 8.5 vs 31.0 movements ± 8.0, P < .01, respectively). Radial task: The experts took less time, had shorter path lengths, and used fewer movements than the trainees (24.2 seconds ± 10.6 vs 33.1 seconds ± 16.9, P < .01; 2.0 m ± 0.5 vs 3.0 m ± 1.9, P < .001; and 36.5 movements ± 15.0 vs 54.5 movements ± 28.0, P < .001, respectively). The trainees had a shorter path length for their dominant hand than their nondominant hand (3.0 m ± 1.9 vs 3.5 m ± 1.9, P < .05). The expert palpatory group had a shorter path length than the ultrasound and limited experience groups (1.8 m ± 0.4 vs 2.0 m ± 0.4 and 2.3 m ± 1.2, respectively, P < .05). CONCLUSIONS: Electromagnetic hand motion tracking can differentiate between the expert and trainee operators for simulated interventional tasks.
Assuntos
Cateterismo Periférico , Competência Clínica , Fenômenos Eletromagnéticos , Mãos , Destreza Motora , Artéria Radial , Radiografia Intervencionista , Radiologistas , Fenômenos Biomecânicos , Estudos de Viabilidade , Humanos , Projetos Piloto , Estudos Prospectivos , Punções , Fatores de TempoRESUMO
PURPOSE: Water equivalent diameter (WED) is a robust patient-size descriptor. Localizer-based WED estimation is less sensitive to truncation errors resulting from limited field of view, and produces WED estimates at different locations within one localizer radiograph, prior to the initiation of axial scans. This method is considered difficult to implement by the clinical community due to the necessary calibration between localizer pixel values (LPV) and attenuation, and the unknown stability of calibration results across scanners and over time. We investigated the stability of calibration results across 25 computed tomography (CT) scanners from three medical centers, and their stability over 3 â¼ 29 months for 14 of those scanners. METHODS: Localizer and axial images of ACR and body computed tomography dose index phantoms were acquired, using routine clinical techniques (120 kV and lateral localizers) on each of the 25 CT scanners: 8 GE scanners (CT750HD, VCT, and Revolution), 8 Siemens scanners (Definition AS, Force, Flash, and Edge), 5 Canon scanners (Aquilion-One, Aquilion-Prime80, and Aquilion-64), and 4 Philips scanners (iCT 256, iQon, and Ingenuity). By associating axial images with the corresponding localizer lines, the relationship between the scaled water equivalent area (WEA) and averaged LPV were established through regression analysis. RESULTS: Linear relationships between the scaled WEA and the averaged LPV were observed in all 25 CT scanners ( R 2 > 0.999 ). Calibration parameters were similar for CT scanners from the same vendor: the coefficients of variation (COV) were ≤ 1% in all four vendor groups for the calibration slope, and < 7% for the intercept. By analyzing the deviation of WED resulted from errors in the calibration slope or intercept alone, we derived the tolerance ranges for the slope or intercept for a given WED error level. The variation of slope and intercept from different CT scanners of the same vendor introduced <±2.5% error in the estimated WED for subjects of 20 and 30-cm WED. The calibration parameters remained stable over time, with the maximum deviations all within the boundary values that introduce ±2.5% error in the estimated WED for subjects of 20 and 30-cm WED. CONCLUSIONS: The stability in calibration results among CT scanners of the same vendor and over time demonstrated the feasibility of implementing WED estimation for routine clinical use.
Assuntos
Tomografia Computadorizada por Raios X/instrumentação , Água , Calibragem , Humanos , Estudos Longitudinais , Imagens de FantasmasRESUMO
OBJECTIVE: The purpose of this study is to provide a more accurate estimation of the radiation dose of contrast-enhanced spectral mammography (CESM) relative to that of 2D digital mammography and tomosynthesis using phantom and patient data and an accepted dosimetry protocol that eliminates vendor-specific average glandular dose (AGD) estimates while including breast density. MATERIALS AND METHODS: Patient and phantom AGD estimation was performed using two vendors (system 1 and system 2) in five imaging modes, including 2D, 3D, and CESM imaging. Patient AGD was retrospectively estimated from 45 patients who underwent mammography with all imaging modes during 2012-2016. Patient and phantom AGD were estimated using accepted European and International Atomic Energy Agency protocols for dosimetry and were compared across imaging modes using a paired t test with Bonferroni correction. RESULTS: Phantom data showed that the imaging modes with the lowest to highest AGDs were system 1 2D, followed by system 2 2D and system 2 3D, which had comparable values (p = 0.6), followed by system 1 CESM, and then by system 2 2D plus 3D. One hundred eighty views in 45 patients showed that the system 1 CESM AGD was 1.8 times greater than the system 1 2D AGD (p < 0.001), 1.2 times greater than the system 2 2D AGD (p < 0.001), 1.2 times greater than the system 2 3D AGD (p < 0.001), and 0.6 times less than the system 2 2D plus 3D AGD (p < 0.001). CONCLUSION: The CESM dose for system 1 is within an acceptable range as compared with other commonly performed mammographic examinations and should not preclude its use as a diagnostic breast imaging tool.
Assuntos
Neoplasias da Mama/diagnóstico por imagem , Meios de Contraste/administração & dosagem , Iohexol/administração & dosagem , Mamografia/instrumentação , Adulto , Idoso , Feminino , Humanos , Pessoa de Meia-Idade , Imagens de Fantasmas , Doses de RadiaçãoRESUMO
PURPOSE: Water equivalent diameter (Dw) reflects patient's attenuation and is a sound descriptor of patient size, and is used to determine size-specific dose estimator from a CT examination. Calculating Dw from CT localizer radiographs makes it possible to utilize Dw before actual scans and minimizes truncation errors due to limited reconstructed fields of view. One obstacle preventing the user community from implementing this useful tool is the necessity to calibrate localizer pixel values so as to represent water equivalent attenuation. We report a practical method to ease this calibration process. METHODS: Dw is calculated from water equivalent area (Aw) which is deduced from the average localizer pixel value (LPV) of the line(s) in the localizer radiograph that correspond(s) to the axial image. The calibration process is conducted to establish the relationship between Aw and LPV. Localizer and axial images were acquired from phantoms of different total attenuation. We developed a program that automates the geometrical association between axial images and localizer lines and manages the measurements of Dw and average pixel values. We tested the calibration method on three CT scanners: a GE CT750HD, a Siemens Definition AS, and a Toshiba Acquilion Prime80, for both posterior-anterior (PA) and lateral (LAT) localizer directions (for all CTs) and with different localizer filters (for the Toshiba CT). RESULTS: The computer program was able to correctly perform the geometrical association between corresponding axial images and localizer lines. Linear relationships between Aw and LPV were observed (with R2 all greater than 0.998) on all tested conditions, regardless of the direction and image filters used on the localizer radiographs. When comparing LAT and PA directions with the same image filter and for the same scanner, the slope values were close (maximum difference of 0.02 mm), and the intercept values showed larger deviations (maximum difference of 2.8 mm). Water equivalent diameter estimation on phantoms and patients demonstrated high accuracy of the calibration: percentage difference between Dw from axial images and localizers was below 2%. With five clinical chest examinations and five abdominal-pelvic examinations of varying patient sizes, the maximum percentage difference was approximately 5%. CONCLUSIONS: Our study showed that Aw and LPV are highly correlated, providing enough evidence to allow for the Dw determination once the experimental calibration process is established.
Assuntos
Modelos Biológicos , Doses de Radiação , Tomografia Computadorizada por Raios X/métodos , Encéfalo/diagnóstico por imagem , Calibragem , Humanos , Modelos Lineares , Imagens de Fantasmas , Software , Tomógrafos Computadorizados , Tomografia Computadorizada por Raios X/instrumentação , Tronco/diagnóstico por imagem , ÁguaRESUMO
Orexin (also known as hypocretin) neurons are considered a key component of the ascending arousal system. They are active during wakefulness, at which time they drive and maintain arousal, and are silent during sleep. Their activity is controlled by long-range inputs from many sources, as well as by more short-range inputs, including from presumptive GABAergic neurons in the lateral hypothalamus/perifornical region (LH/PF). To characterize local GABAergic input to orexin neurons, we used channelrhodopsin-2-assisted circuit mapping in brain slices. We expressed channelrhodopsin-2 in GABAergic neurons (Vgat+) in the LH/PF and recorded from genetically identified surrounding orexin neurons (LH/PFVgat â Orx). We performed all experiments in mice of either sex. Photostimulation of LH/PF GABAergic neurons inhibited the firing of orexin neurons through the release of GABA, evoking GABAA-mediated IPSCs in orexin neurons. These photo-evoked IPSCs were maintained in the presence of TTX, indicating direct connectivity. Carbachol inhibited LH/PFVgat â Orx input through muscarinic receptors. By contrast, application of orexin was without effect on LH/PFVgat â Orx input, whereas dynorphin, another peptide produced by orexin neurons, inhibited LH/PFVgat â Orx input through κ-opioid receptors. Our results demonstrate that orexin neurons are under inhibitory control by local GABAergic neurons and that this input is depressed by cholinergic signaling, unaffected by orexin and inhibited by dynorphin. We propose that local release of dynorphin may, via collaterals, provides a positive feedback to orexin neurons and that, during wakefulness, orexin neurons may be disinhibited by acetylcholine and by their own release of dynorphin.SIGNIFICANCE STATEMENT The lateral hypothalamus contains important wake-promoting cell populations, including orexin-producing neurons. Intermingled with the orexin neurons, there are other cell populations that selectively discharge during nonrapid eye movement or rapid eye movement sleep. Some of these sleep-active neurons release GABA and are thought to inhibit wake-active neurons during rapid eye movement and nonrapid eye movement sleep. However, this hypothesis had not been tested. Here we show that orexin neurons are inhibited by a local GABAergic input. We propose that this local GABAergic input inhibits orexin neurons during sleep but that, during wakefulness, this input is depressed, possibly through cholinergically mediated disinhibition and/or by release of dynorphin from orexin neurons themselves.
Assuntos
Neurônios GABAérgicos/fisiologia , Região Hipotalâmica Lateral/metabolismo , Região Hipotalâmica Lateral/fisiologia , Orexinas/fisiologia , Animais , Mapeamento Encefálico , Carbacol/farmacologia , Channelrhodopsins/fisiologia , Dinorfinas/farmacologia , Potenciais Pós-Sinápticos Excitadores/fisiologia , Feminino , Neurônios GABAérgicos/efeitos dos fármacos , Região Hipotalâmica Lateral/efeitos dos fármacos , Masculino , Camundongos , Agonistas Muscarínicos/farmacologia , Orexinas/farmacologia , Sistema Nervoso Parassimpático/fisiologia , Estimulação Luminosa , Córtex Pré-Frontal/metabolismo , Receptores de GABA-A/metabolismo , Tetrodotoxina/farmacologia , Proteínas Vesiculares de Transporte de Aminoácidos Inibidores/fisiologiaRESUMO
As potential activators of brown adipose tissue (BAT), mild cold exposure and sympathomimetic drugs have been considered as treatments for obesity and diabetes, but whether they activate the same pathways is unknown. In 10 healthy human volunteers, we found that the sympathomimetic ephedrine raised blood pressure, heart rate, and energy expenditure, and increased multiple circulating metabolites, including glucose, insulin, and thyroid hormones. Cold exposure also increased blood pressure and energy expenditure, but decreased heart rate and had little effect on metabolites. Importantly, cold increased BAT activity as measured by (18)F-fluorodeoxyglucose PET-CT in every volunteer, whereas ephedrine failed to stimulate BAT. Thus, at doses leading to broad activation of the sympathetic nervous system, ephedrine does not stimulate BAT in humans. In contrast, mild cold exposure stimulates BAT energy expenditure with fewer other systemic effects, suggesting that cold activates specific sympathetic pathways. Agents that mimic cold activation of BAT could provide a promising approach to treating obesity while minimizing systemic effects.
Assuntos
Tecido Adiposo Marrom/fisiologia , Temperatura Baixa , Epinefrina/farmacologia , Simpatomiméticos/farmacologia , Tecido Adiposo Marrom/efeitos dos fármacos , Humanos , Imagem Multimodal , Tomografia por Emissão de Pósitrons , Tomografia Computadorizada por Raios XRESUMO
BACKGROUND: Debate continues about which liver transplantation candidates with impaired renal function should undergo liver transplant alone versus simultaneous liver-kidney transplantation (SLK). Identifying predictors of native kidney function recovery after SLK requires an accurate measure of the relative function of all three kidneys in patients with SLK. METHODS: The distance of a transplanted kidney from the renal scan camera can be substantially different from that of native kidneys. We developed a technique to correct attenuation of counts of all three kidneys based on their depth. RESULTS: In our series of 13 SLK recipients, attenuation correction increased the measured renal function of native kidneys by up to 40%, demonstrating the importance of this procedure for accurately measuring kidney function. Eight patients met the United Network for Organ Sharing (UNOS)-proposed criteria for receiving a SLK, but four of these still had significant native kidney function (>40% of total function) after transplant. Five patients did not meet the UNOS-proposed criteria for SLK, yet only one of these had native kidney function recovery. CONCLUSION: The criteria proposed by UNOS to determine that SLK is indicated, and thus that native kidney recovery is not expected, are not always accurate. Further study of factors associated with native kidney recovery after SLK is required.
Assuntos
Transplante de Rim , Rim/cirurgia , Transplante de Fígado , Adulto , Idoso , Boston , Feminino , Humanos , Rim/diagnóstico por imagem , Rim/fisiopatologia , Transplante de Rim/efeitos adversos , Transplante de Fígado/efeitos adversos , Masculino , Pessoa de Meia-Idade , Imagem Multimodal , Seleção de Pacientes , Tomografia por Emissão de Pósitrons , Guias de Prática Clínica como Assunto , Valor Preditivo dos Testes , Compostos Radiofarmacêuticos , Recuperação de Função Fisiológica , Estudos Retrospectivos , Medição de Risco , Fatores de Risco , Fatores de Tempo , Tomografia Computadorizada por Raios X , Resultado do TratamentoRESUMO
AIM: Physiologic activity of 18F-fluorodeoxyglucose (FDG) in the intestinal tract occurs frequently in patients undergoing PET/computed tomography (CT) imaging, appearing most often in the colon. The purpose of this study is to determine the localization of the FDG within the colon. We hypothesize that intestinal FDG activity is intraluminal. METHODS: In a prospective Institutional Review Board-approved and Health Insurance Portability and Accountability Act-compliant study, patients with physiologic colonic FDG activity on PET/CT scans were enrolled to undergo repeat imaging 2 h after stimulation of colonic motility with a high-fat meal. RESULTS: We identified 13 patients who had focal FDG activity in their colon during a routine clinical PET/CT scan. After administration of a high-fat meal, 10 patients (77%) demonstrated antegrade movement of FDG along the colon, consistent with luminal clearance. CONCLUSION: Our results suggest that normal physiologic FDG activity within the large intestine, seen on PET/CT scans, is intraluminal.
Assuntos
Colo/fisiologia , Fluordesoxiglucose F18/farmacocinética , Imagem Multimodal/métodos , Tomografia por Emissão de Pósitrons , Compostos Radiofarmacêuticos/farmacocinética , Tomografia Computadorizada por Raios X , Colo/metabolismo , Humanos , Intestino Grosso/metabolismo , Intestino Grosso/fisiologia , Projetos Piloto , Estudos Prospectivos , Distribuição TecidualRESUMO
OBJECTIVE: Assessing the relative function of each of the three kidneys using nuclear scintigraphy with standard planar imaging in patients having undergone kidney transplant is problematic because of the different photon-attenuation factors associated with native versus transplanted kidneys. To address this, we applied a correction for the attenuation of 140-keV photons based on measurements taken on cross-sectional anatomical images. We performed a validation of the method using single-photon emission computed tomography/computed tomography (SPECT/CT). METHODS: Abdominal CT scans of 13 patients who had undergone simultaneous liver-kidney transplants were examined for kidney depth. Ten of those patients had undergone Tc-99m-mercaptoacetyltriglycine (MAG3) renal scans, using a Philips Precedence SPECT/CT scanner by which abdominal CT and renal SPECT acquisition followed the planar scintigraphic renogram. Kidney depth at the level of the renal hilum was measured on the concurrently acquired CT images, and it was used to derive an attenuation correction factor (ACF) that was applied to the background-subtracted activity in the planar scintigraphic renogram. RESULTS: ACFs calculated from kidney depths ranged from 1.31 to 4.33. The ratio of ACFs for transplant to native kidneys ranged from 0.63 to 1.51, with an average of 0.90. Applying attenuation correction when calculating relative function increased the value of native kidney function by as much as 40%. CONCLUSION: Attenuation correction through measurements taken on anatomical images, preferably obtained concurrently using a hybrid SPECT/CT scanner, should improve the accuracy of functional measurements in renal scintigraphy. This improved accuracy is clinically important in assessing the relative function of native and transplant kidneys in recipients of simultaneous liver-kidney transplants.
Assuntos
Processamento de Imagem Assistida por Computador/métodos , Transplante de Rim , Rim/fisiopatologia , Transplante de Fígado , Tecnécio Tc 99m Mertiatida , Tomografia Computadorizada de Emissão de Fóton Único/métodos , Tomografia Computadorizada por Raios X/métodos , Humanos , Rim/diagnóstico por imagem , Rim/cirurgia , Transplante de Rim/diagnóstico por imagem , Transplante de Fígado/diagnóstico por imagem , Fótons , Estudos RetrospectivosRESUMO
UNLABELLED: Extravasation of therapeutic (90)Y-ibritumomab tiuxetan can cause significant injury. Detection of extravasated (90)Y using a γ-camera for patients undergoing (90)Y-ibritumomab tiuxetan therapy is a challenge because of the inherently low efficiency of bremsstrahlung imaging and the interference of prompt and scattered photons from (111)In that are still present in the body at the time of (90)Y injection. We have configured a γ-camera to image bremsstrahlung radiation from superficial (90)Y in the presence of (111)In and evaluated the effectiveness using phantoms. METHODS: Phantoms were constructed to contain (90)Y and (111)In with activity levels and with a geometry approximating conditions in a patient being scanned for evaluation of possible extravasation in the antecubital fossa. Imaging was performed using a camera equipped with medium-energy general-purpose (MEGP) and high-energy general-purpose (HEGP) collimators. RESULTS: The contrast that developed between the patch representing extravasated solution and the background was comparable for MEGP and HEGP collimators. With MEGP collimators and 5-min acquisitions, a patch containing 8.3 MBq (220 µCi) distributed over an elliptic area of 7 × 11 cm was clearly discernable. CONCLUSION: With our experimental arrangement, the lower limit of detection is approximately 8 MBq. We calculate that an extravasation of this much (90)Y would result in an absorbed dose to the skin and subcutaneous tissue of 2.5 Gy, which is close to the threshold for skin damage. This technique is therefore sensitive enough to be of use in the clinic when extravasation of (90)Y is suspected.
Assuntos
Anticorpos Monoclonais/farmacocinética , Anticorpos Monoclonais/uso terapêutico , Extravasamento de Materiais Terapêuticos e Diagnósticos/diagnóstico por imagem , Cintilografia/métodos , Imagens de Fantasmas , Cintilografia/instrumentaçãoRESUMO
PURPOSE: The objective of this study is to evaluate requirements for radionuclide-based solid tumor therapy by assessing the radial dose distribution of beta-particle-emitting and alpha-particle-emitting molecules localized either solely within endothelial cells of tumor vasculature or diffusing from the vasculature throughout the adjacent viable tumor cells. METHODS: Tumor blood vessels were modeled as a group of microcylindrical layers comprising endothelial cells (one-cell thick, 10 microm diameter), viable tumor cells (25-cell thick, 250 microm radius), and necrotic tumor region (> 250 microm from any blood vessel). Sources of radioactivity were assumed to distribute uniformly in either endothelial cells or in concentric cylindrical 10 microm shells within the viable tumor-cell region. The EGSnrc Monte Carlo simulation code system was used for beta particle dosimetry and a dose-point kernel method for alpha particle dosimetry. The radioactive decays required to deposit cytocidal doses (> or = 100 Gy) in the vascular endothelial cells (endothelial cell mean dose) or, alternatively, at the tumor edge [tumor-edge mean dose (TEMD)] of adjacent viable tumor cells were then determined for six beta (32P, 33P, 67Cu, 90Y 131I, and 1188Re) and two alpha (211At and 213Bi) particle emitters. RESULTS: Contrary to previous modeling in targeted radionuclide therapy dosimetry of solid tumors, the present work restricts the region of tumor viability to 250 microm around tumor blood vessels for consistency with biological observations. For delivering > or = 100 Gy at the viable tumor edge (TEMD) rather than throughout a solid tumor, energetic beta emitters 90Y, 32P, and 188Re can be effective even when the radionuclide is confined to the blood vessel (i.e., no diffusion into the tumor). Furthermore, the increase in tumor-edge dose consequent to beta emitter diffusion is dependent on the energy of the emitted beta particles, being much greater for lower-energy emitters 131I, 67Cu, and 33P relative to higher-energy emitters 90Y, 32P, and 188Re. Compared to alpha particle emitters, a approximately 150-400 times higher number of beta-particle-emitting radioactive atoms is required to deposit the same dose in tumor neovasculature. However, for the alpha particle emitters 211At and 213Bi to be effective in irradiating viable tumor-cell regions in addition to the vasculature the carrier molecules must diffuse substantially from the vasculature into the viable tumor. CONCLUSION: The presented data enable comparison of radionuclides used for antiangiogenic therapy on the basis of their radioactive decay properties, tumor neovasculature geometry, and tumor-cell viability. For alpha particle emitters or low-energy beta particle emitters, the targeting carrier molecule should be chosen to permit the radiopharmaceutical to diffuse from the endothelial wall of the blood vessel, while for long-range energetic beta particle emitters that target neovasculature, a radiopharmaceutical that binds to newly formed endothelial cells and does not diffuse is preferable. The work is a first approximation to modeling of tumor neovasculature that ignores factors such as pharmacokinetics and targeting capability of carrier molecules. The calculations quantify the interplay between irradiation of neovasculature, the surrounding viable tumor cells, and the physical properties of commonly used radionuclides and can be used to assist estimation of radioactivity to be administered for neovasculature-targeted tumor therapy.
Assuntos
Modelos Biológicos , Neoplasias/fisiopatologia , Neoplasias/radioterapia , Neovascularização Patológica/fisiopatologia , Neovascularização Patológica/radioterapia , Radioisótopos/uso terapêutico , Animais , Simulação por Computador , Humanos , Neoplasias/irrigação sanguínea , Compostos Radiofarmacêuticos/uso terapêuticoRESUMO
OBJECTIVE: The aim of this study was to evaluate prospectively the effects of respiratory gating during FDG PET/CT on the determination of lesion size and the measurement of tracer uptake in patients with pulmonary nodules in a clinical setting. SUBJECTS AND METHODS: Eighteen patients with known pulmonary nodules (nine women, nine men; mean age, 61.4 years) underwent conventional FDG PET/CT and respiratory-gated PET acquisitions during their scheduled staging examinations. Maximum, minimum, and average standardized uptake values (SUVs) and lesion size and volume were determined with and without respiratory gating. The results were then compared using the two-tailed Student's t test and the nonparametric Wilcoxon's test to assess the effects of respiratory gating on PET acquisitions. RESULTS: Respiratory gating reduced the measured area of lung lesions by 15.5%, the axial dimension by 10.3%, and the volume by 44.5% (p = 0.014, p = 0.007, and p = 0.025, respectively). The lesion volumes in gated studies were closer to those assessed by standard CT (difference decreased by 126.6%, p = 0.025). Respiratory gating increased the measured maximum SUV by 22.4% and average SUV by 13.3% (p < 0.001 and p = 0.002). CONCLUSION: Our findings suggest that the use of PET respiratory gating in PET/CT results in lesion volumes closer to those assessed by CT and improved measurements of tracer uptake for lesions in the lungs.
Assuntos
Tomografia por Emissão de Pósitrons/métodos , Técnicas de Imagem de Sincronização Respiratória/métodos , Nódulo Pulmonar Solitário/diagnóstico por imagem , Tomografia Computadorizada por Raios X/métodos , Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Fluordesoxiglucose F18 , Humanos , Aumento da Imagem/métodos , Processamento de Imagem Assistida por Computador , Metástase Linfática , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Compostos Radiofarmacêuticos , Sensibilidade e Especificidade , Estatísticas não ParamétricasRESUMO
UNLABELLED: PET/CT imaging with (18)F-FDG has been used to detect inflammation in carotid and aortic plaque; its use in detecting coronary plaque has been limited by avid (18)F-FDG uptake by the myocardium. We investigated whether (18)F-FDG PET/CT could be used to image inflammation in coronary arteries as a potential noninvasive method to detect vulnerable plaque. METHODS: We retrospectively studied 32 patients treated for malignancy who underwent (18)F-FDG PET/CT and concomitant cardiac catheterization. As part of the recently described protocol, all patients were instructed to eat a low-carbohydrate, high-fat meal the night before and drink a vegetable oil drink the morning of the study. We reviewed the patients' baseline characteristics and their (18)F-FDG PET/CT scans for adequacy of myocardial uptake suppression and correlated the presence of angiographically apparent plaque with (18)F-FDG uptake in the major coronary arteries. Two independent observers assessed the angiographic images and (18)F-FDG PET scans. RESULTS: A total of 95% of patients had 2 or more coronary disease risk factors, and 25% had unstable symptoms; 30% of index catheterizations resulted in intervention. In 20 of 32 patients (63%), myocardial suppression was good (12) or adequate (8). Inadequate suppression was due to self-reported dietary nonadherence. Patients with good, adequate, and poor suppression had maximal myocardial standardized uptake values of 2.8 +/- 0.7, 5.0 +/- 1.3, and 17.0 +/- 9.7, respectively. We identified (18)F-FDG uptake in 15 patients in 1 or more coronary segments. A trend to significance in correlation between presence of angiographic disease and signal in the vessel was observed (P = 0.07; 80 vessels examined). A total of 7 patients with significant coronary artery disease had aortic (18)F-FDG uptake. CONCLUSION: In this retrospective study, we demonstrated the potential use of (18)F-FDG PET in imaging of inflammation in coronary arteries. The potential of (18)F-FDG PET is also being investigated in a prospective study.
Assuntos
Arterite/diagnóstico , Arterite/metabolismo , Doença da Artéria Coronariana/diagnóstico , Doença da Artéria Coronariana/metabolismo , Fluordesoxiglucose F18/farmacocinética , Tomografia por Emissão de Pósitrons/métodos , Tomografia Computadorizada por Raios X/métodos , Dieta com Restrição de Carboidratos/métodos , Gorduras na Dieta/farmacocinética , Humanos , Aumento da Imagem/métodos , Miocárdio/metabolismo , Compostos Radiofarmacêuticos/farmacocinética , Reprodutibilidade dos Testes , Sensibilidade e EspecificidadeRESUMO
A blind performance test was conducted to evaluate dose-calibrator measurements at nuclear pharmacies in the United States (US). Two test-sample geometries were chosen to represent those used for measurements of 90Y-ibritumomab tiuxetan (ZEVALIN). The radioactivity concentration of test-samples was verified by the US National Institute of Standards and Technology. Forty-five results were reported by 10 participants. Eighty percent of reported values were within the US Pharmacopoeia content standard (+/-10%) for 90Y-ZEVALIN. All results were within US Nuclear Regulatory Commission conformance limits (+/-20%) for defining therapeutic misadministrations.
Assuntos
Anticorpos Monoclonais/análise , Compostos Radiofarmacêuticos/análise , Radioisótopos de Ítrio/análise , Instituições de Assistência Ambulatorial/normas , Anticorpos Monoclonais/uso terapêutico , Humanos , Neoplasias/radioterapia , Medicina Nuclear/normas , Farmácias/normas , Projetos Piloto , Controle de Qualidade , Radioimunoterapia , Radiometria/métodos , Radiometria/normas , Compostos Radiofarmacêuticos/normas , Compostos Radiofarmacêuticos/uso terapêutico , Dosagem Radioterapêutica , Padrões de Referência , Estados Unidos , Radioisótopos de Ítrio/normas , Radioisótopos de Ítrio/uso terapêuticoRESUMO
OBJECTIVE: Many of the functions necessary for imaging and analyzing nuclear medicine studies are not available on radiology PACS. Over the past 20 years, we have developed a user-friendly, easily installed software package for nuclear medicine study analysis, display, Web access, and database storage and an integrated display for fused PET/CT. We are making this software available as free shareware that can be used without a license on any PC. The software package was developed as a cooperative effort between house and attending staff and our nuclear medicine programmer. Particular emphasis was put on making functions intuitive and user friendly. CONCLUSION: A shareware nuclear medicine PACS software package including a display for fused PET/CT studies has been developed, extensively clinically tested, and is freely available on the Internet.